IceCure Medical Ltd.ICCMEarnings & Financial Report
Nasdaq
IceCure Medical Ltd. develops and commercializes minimally invasive cryoablation medical devices designed to treat benign and malignant tumors, including breast, lung, kidney and bone lesions. It caters to healthcare providers across North America, Europe, and Asia-Pacific, delivering accessible, low-risk minimally invasive tumor treatment solutions for clinical settings.
What changed in IceCure Medical Ltd.'s 6-K — 2023 vs 2024
No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.